Chrystalleni Hadjicharalambous
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chrystalleni Hadjicharalambous has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Beniamino Terzo Cenci Goga
Dipartimento di Medicina Veterinaria, Università degli Studi di Perugia, 06126 Perugia, Italy
1 shared publication Daphne Chandrinou
Crystal Engineering, Growth and Design Laboratory, Department of Chemistry, University of Crete, Heraklion, Crete, GR-71003, Greece.
1 shared publication- Duane Choquesillo-Lazarte
Laboratorio de Estudios Cristalográficos, IACT-CSIC, Avda. de las Palmeras 4, Armilla 18100, Spain
1 shared publication - Konstantinos D. Demadis
Crystal Engineering, Growth and Design Laboratory, Department of Chemistry, University of Crete, Voutes Campus, Heraklion, Crete GR-71003, Greece
1 shared publication - Konstantinos E. Papathanasiou
Crystal Engineering, Growth and Design Laboratory, Department of Chemistry, University of Crete, Voutes Campus, Crete, GR-71003, Greece
1 shared publication - Luca Grispoldi
Department of Veterinary Medicine, University of Perugia, 06126 Perugia, Italy
1 shared publication
Latest Publications
- Open Access
- 27 March 2020
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 56 (38) , 5166-5169
Self-sacrificial MOFs for ultra-long controlled release of bisphosphonate anti-osteoporotic drugs
In this paper we report drug delivery systems that are based on phosphonate MOFs. These employ biologically-acceptable metal ions (e.g. Ca2+ and Mg2+) and several anti-osteoporosis bisphosphonate drugs (etidronate, pamidronate, alendronate and neridronate), as the organic linkers. These materials have been synthesized, structurally characterized, and studied for the self-sacrificial release (by pH-driven dissolution) of the bisphosphonate active ingredient. They exhibit variable release rates and final % release, depending on the actual structure of the metal-bisphosphonate material. Their cytotoxicity profiles match those of the active ingredients.
- 27 March 2020
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 56 (38) , 5166-5169
Open AccessSelf-sacrificial MOFs for ultra-long controlled release of bisphosphonate anti-osteoporotic drugs
In this paper we report drug delivery systems that are based on phosphonate MOFs. These employ biologically-acceptable metal ions (e.g. Ca2+ and Mg2+) and several anti-osteoporosis bisphosphonate drugs (etidronate, pamidronate, alendronate and neridronate), as the organic linkers. These materials have been synthesized, structurally characterized, and studied for the self-sacrificial release (by pH-driven dissolution) of the bisphosphonate active ingredient. They exhibit variable release rates and final % release, depending on the actual structure of the metal-bisphosphonate material. Their cytotoxicity profiles match those of the active ingredients.